You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
SciBase Q3’24: Waiting for the clear waters
SciBase kept building its commercial momentum in the US, where it achieved strong revenue growth in Q3. Yet, the major news of the day was the large capital raise, which would carry the company to cash flow positivity. Analyst Antti Luiro’s thoughts in the interview.
Report: https://www.inderes.fi/research/scibase-q324-approaching-a-turning-point
Content:
00:00 Intro
00:12 Summary of Q3
01:47 US market
05:08 Financial situation and warrants
10:20 Positive drivers and risks
Aktier i Vælten - Novo Nordisk: Vi må vente på re-eksamen efter skuffende data
Introduction to the Helsinki Stock Exchange | Company Night Dec. 16, 2024
Surgical Science Sweden, Audiocast with teleconference, Press Conference, 2024
GomSpace – Management Q&A
ExpreS2ion Biotech – A look back at 2024 with CEO
Vis alle videoer